Neil Solomons is Chief Medical Officer at Aurinia Pharmaceuticals Inc. (AUPH). They have made 7 open-market trades across 1 company since 2021, most recently 2022-03-02.
CIK 0001837720
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AUPH | 95,799 | $1.6M |
Shares reported on the most recent Form 4, priced at the 2022-03-04 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AUPH | SELL | 2022-03-02 | 2022-03-04 | $12.01 | $116K | +2.7% | +15.7% | +2.9% |
| AUPH | SELL | 2021-11-09 | 2021-11-12 | $30.03 | $7.5M | -32.8% | -32.1% | -36.4% |
| AUPH | SELL | 2021-11-01 | 2021-11-03 | $31.64 | $1.4M | -12.8% | -39.7% | -43.1% |
| AUPH | SELL | 2021-09-10 | 2021-09-14 | $19.84 | $3.0M | +9.8% | -0.6% | -6.0% |
| AUPH | SELL | 2021-08-25 | 2021-08-26 | $15.85 | $79K | +7.4% | +30.0% | +8.8% |
| AUPH | SELL | 2021-08-09 | 2021-08-10 | $16.03 | $721K | -9.8% | +27.9% | +107.0% |
| AUPH | SELL | 2021-03-12 | 2021-03-15 | $13.49 | $540K | -12.3% | -12.1% | -11.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.